Adam Dangoor,Beatrice Seddon,Craig Gerrand,Ian Judson,Jeremy Whelan,Robert Grimer
Bristol Cancer Institute, Bristol Haematology & Oncology Centre, University Hospitals Bristol NHS Trust, Bristol, BS2 8ED UK.,Department of Oncology, University College London Hospital NHS Trust, London, NW1 2PG UK.,Royal Marsden NHS Foundation Trust, London, SW3 6JJ UK.,Royal Orthopaedic Hospital NHS Trust, Birmingham, B31 2AP UK.,The Newcastle upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, Newcastle-upon-Tyne, NE7 7DN UK.
Publication
Summary
These guidelines are an update of the previous version published in 2010 (Grimer et al. in Sarcoma 2010:506182, 2010). The original guidelines were drawn up following a consensus meeting of UK sarcoma specialists convened under the auspices of the British Sarcoma Group (BSG) and were intended to provide a framework for the multidisciplinary care of patients with soft tissue sarcomas. This current version has been updated and amended with reference to other European and US guidance. There are specific recommendations for the management of selected subtypes of disease including retroperitoneal and uterine sarcomas, as well as aggressive fibromatosis (desmoid tumours) and other borderline tumours commonly managed by sarcoma services. An important aim in sarcoma management is early diagnosis and prompt referral. In the UK, any patient with a suspected soft tissue sarcoma should be referred to one of the specialist regional soft tissues sarcoma services, to be managed by a specialist sarcoma multidisciplinary team.
Stay Up to Date as We Uncover More About Desmoid Tumors
